Director Oh Kyung-seung (left) of Kosin University Gospel Hospital and CEO Kim Jong-rak of DeepHelix signed a business agreement on AI-based medical technology commercialization on the 6th.

Director Oh Kyung-seung (left) of Kosin University Gospel Hospital and CEO Kim Jong-rak of DeepHelix signed a business agreement on AI-based medical technology commercialization on the 6th.

View original image


[Asia Economy Yeongnam Reporting Headquarters Reporter Kim Yong-woo] Kosin University Gospel Hospital signed a business agreement on June 6 with 'DeepHelix' regarding the commercialization of artificial intelligence-based medical technology.


According to the agreement signed in the conference room of Building 1 at the hospital on the same day, the institutions will develop AI-based medical, disease, and cancer diagnostic support solutions.


They will also simultaneously conduct AI-based demonstration projects within the Eco Delta Smart City Health Cluster project.


DeepHelix, known as a leading company in AI medical imaging alongside Lunit, a pioneer in medical artificial intelligence, operates not only a medical AI business platform but also corporate business analysis and educational platform businesses such as We-Zum.


They are commercializing medical devices that analyze the morphology of peripheral blood using medical AI and diagnose blood diseases through microscopy.


Additionally, DeepHelix is jointly conducting early screening projects for thyroid cancer using ultrasound and cytology tests in the Philippines, Vietnam, and Cambodia, in collaboration with Kosin University Hospital and UCLA Medical Center in the United States.


By integrating DeepHelix's AI technology with microscopes on site, various international joint research projects will also be carried out in the future.



Director Oh Kyung-seung of Kosin University Hospital stated, "We are pleased to introduce DeepHelix, a super rookie in medical AI, with its AI blood diagnosis and thyroid cancer diagnostic platform," adding, "Through the establishment of a global AI cancer center suitable for Eco Delta Smart City, we will play a significant role in the global healthcare market."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing